168 related articles for article (PubMed ID: 8806678)
1. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins.
White DW; Gilmore TD
Oncogene; 1996 Sep; 13(5):891-9. PubMed ID: 8806678
[TBL] [Abstract][Full Text] [Related]
2. The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells.
White DW; Roy A; Gilmore TD
Oncogene; 1995 Mar; 10(5):857-68. PubMed ID: 7898928
[TBL] [Abstract][Full Text] [Related]
3. Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display.
You M; Bose HR
Methods; 1998 Dec; 16(4):373-85. PubMed ID: 10049645
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.
White DW; Pitoc GA; Gilmore TD
Mol Cell Biol; 1996 Mar; 16(3):1169-78. PubMed ID: 8622661
[TBL] [Abstract][Full Text] [Related]
5. Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins.
Diehl JA; McKinsey TA; Hannink M
Mol Cell Biol; 1993 Mar; 13(3):1769-78. PubMed ID: 8441412
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
[TBL] [Abstract][Full Text] [Related]
7. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein.
You M; Ku PT; Hrdlicková R; Bose HR
Mol Cell Biol; 1997 Dec; 17(12):7328-41. PubMed ID: 9372964
[TBL] [Abstract][Full Text] [Related]
8. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
[TBL] [Abstract][Full Text] [Related]
9. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
10. NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
Sif S; Gilmore TD
J Virol; 1993 Dec; 67(12):7612-7. PubMed ID: 8230480
[TBL] [Abstract][Full Text] [Related]
11. The v-Rel oncoprotein complexes with new Rel- and RelA-related proteins in transformed cells.
Xu X; Gélinas C
Virology; 1995 Mar; 207(2):362-8. PubMed ID: 7886940
[TBL] [Abstract][Full Text] [Related]
12. Temperature-sensitive transforming mutants of the v-rel oncogene.
White DW; Gilmore TD
J Virol; 1993 Nov; 67(11):6876-81. PubMed ID: 8411392
[TBL] [Abstract][Full Text] [Related]
13. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
Schatzle JD; Kralova J; Bose HR
J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.
Hrdlicková R; Nehyba J; Bose HR
J Virol; 1995 Jun; 69(6):3369-80. PubMed ID: 7745683
[TBL] [Abstract][Full Text] [Related]
15. v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death.
Zong WX; Farrell M; Bash J; Gélinas C
Oncogene; 1997 Aug; 15(8):971-80. PubMed ID: 9285692
[TBL] [Abstract][Full Text] [Related]
16. A threshold nuclear level of the v-Rel oncoprotein is required for transformation of avian lymphocytes.
Sachdev S; Diehl JA; McKinsey TA; Hans A; Hannink M
Oncogene; 1997 May; 14(21):2585-94. PubMed ID: 9191058
[TBL] [Abstract][Full Text] [Related]
17. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.
Diehl JA; Hannink M
J Virol; 1993 Dec; 67(12):7161-71. PubMed ID: 8230438
[TBL] [Abstract][Full Text] [Related]
18. Three mutations in v-Rel render it resistant to cleavage by cell-death protease caspase-3.
Barkett M; Dooher JE; Lemonnier L; Simmons L; Scarpati JN; Wang Y; Gilmore TD
Biochim Biophys Acta; 2001 Apr; 1526(1):25-36. PubMed ID: 11287119
[TBL] [Abstract][Full Text] [Related]
19. Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.
Kralova J; Schatzle JD; Bargmann W; Bose HR
J Virol; 1994 Apr; 68(4):2073-83. PubMed ID: 8138992
[TBL] [Abstract][Full Text] [Related]
20. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.
Sarkar S; Gilmore TD
Oncogene; 1993 Aug; 8(8):2245-52. PubMed ID: 8336947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
